ADXN
ADDEX THERAP SP ADS (ADXN)
NASDAQ
$6.91+$0.51 (+7.97%)
Price as of Jun 03, 2026 4:04 PM EDT
  • $8.4M
    Market Cap
  • -20.79%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
105,460
-64.66%
298,379
-81.50%
1.6M
+13.39%
1.4M
-51.22%
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
105,460
-64.66%
298,379
-81.50%
1.6M
+13.39%
1.4M
-51.22%
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-671,651
-21.38%
-854,305
-87.73%
-7.0M
-52.52%
-14.7M
+14.21%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
2.3M
+0.21%
2.3M
-53.46%
5.0M
-31.97%
7.3M
+25.45%
Operating Profit
-2.8M
+2.15%
-2.8M
-73.20%
-10.3M
-49.90%
-20.5M
+32.34%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-487
-69.73%
-1,609
-2.13%
-1,644
-93.65%
-25,878
-33.89%
Interest Income and Expense and Net
-487
-69.73%
-1,609
-2.13%
-1,644
-93.65%
-25,878
-33.89%
Total Nonoperating Income and Expense
487
-69.73%
1,609
-95.28%
34,116
+51.49%
22,521
-90.50%
Income before Taxes
-6.7M
-195.36%
7.1M
+166.84%
-10.6M
-49.26%
-20.8M
+35.52%
Income Taxes
0
N/A
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-6.7M
-195.36%
7.1M
+166.84%
-10.6M
-49.26%
-20.8M
+35.52%
Net Income from Continuing Operations Applicable to Common
-6.7M
-195.36%
7.1M
+166.84%
-10.6M
-49.26%
-20.8M
+35.52%
Basic EPS and Net Income
-0.06
-185.71%
0.07
+150.00%
-0.14
-69.57%
-0.46
+2.22%
Diluted EPS and Net Income
-0.06
-185.71%
0.07
+150.00%
-0.14
-69.57%
-0.46
+2.22%
Basic Weighted Average Shares
107.4M
+9.44%
98.1M
+32.04%
74.3M
+64.45%
45.2M
+32.43%
Diluted Weighted Average Shares
107.4M
+9.44%
98.1M
+32.04%
74.3M
+64.45%
45.2M
+32.43%
Balance Sheet
Cash and Cash Equivalents
1.6M
-50.97%
3.3M
-13.55%
3.9M
-44.44%
7.0M
-66.04%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
1.6M
-50.97%
3.3M
-13.55%
3.9M
-44.44%
7.0M
-66.04%
Total Current Assets
1.7M
-52.56%
3.5M
-16.37%
4.2M
-45.91%
7.8M
-64.32%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
707
-37.49%
1,131
-95.00%
22,604
-45.03%
41,121
-42.98%
Total Long-Term Assets
4.7M
-34.37%
7.1M
+1,652.34%
407,280
-10.11%
453,089
-24.49%
Total Assets
6.4M
-40.40%
10.7M
+130.04%
4.6M
-43.95%
8.3M
-63.26%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
1.2M
+49.48%
802,093
-72.28%
2.9M
-11.85%
3.3M
-20.62%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
398,616
+100.37%
198,939
-67.02%
603,136
+593.04%
87,028
-94.10%
Total Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Retained Earnings
-360.1M
+1.90%
-353.4M
-1.96%
-360.4M
+3.02%
-349.9M
+6.32%
Total Stockholders Equity
4.8M
-50.74%
9.7M
+744.83%
1.1M
-76.68%
4.9M
-70.98%
Total Shares Outstanding
151.9M
+18.40%
128.3M
+2.47%
125.2M
+62.31%
77.1M
+103.53%
Cash Flow
Cash from Operating Activities
-2.2M
-59.60%
-5.4M
-32.77%
-8.0M
-51.38%
-16.4M
+11.78%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-680,687
-114.65%
4.6M
+67,992.59%
-6,842
-330.22%
2,972
+109.80%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
1.2M
+1,028.37%
104,918
-98.01%
5.3M
+69.68%
3.1M
-81.08%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
-2,668.88%
+189.03%
-923.40%
+44.87%
-637.42%
-55.81%
-1,442.61%
+171.32%
Return on Assets
-78.96%
-185.72%
92.11%
+156.39%
-163.36%
+21.02%
-134.99%
+87.83%
Return on Equity
-93.16%
-171.45%
130.39%
+137.42%
-348.48%
+82.95%
-190.48%
+95.67%
Revenue Growth
-64.66%
-20.67%
-81.50%
-708.51%
13.39%
+126.15%
-51.22%
+165.70%
Current Ratio
1.40
-68.26%
4.42
+201.67%
1.46
-38.64%
2.39
-55.05%
Cash Ratio
1.37
-67.20%
4.17
+211.85%
1.34
-36.97%
2.12
-57.21%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow